Tacrolimus in refractory polymyositis with interstitial lung disease

Lancet. 1999 May 22;353(9166):1762-3. doi: 10.1016/S0140-6736(99)01927-3.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Autoantibodies / blood
  • Creatine Kinase / blood
  • Female
  • Hand Strength
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Lung Diseases, Interstitial / drug therapy*
  • Lung Diseases, Interstitial / etiology
  • Middle Aged
  • Polymyositis / complications
  • Polymyositis / drug therapy*
  • Polymyositis / immunology
  • Tacrolimus / adverse effects
  • Tacrolimus / therapeutic use*
  • Treatment Outcome

Substances

  • Autoantibodies
  • Immunosuppressive Agents
  • Creatine Kinase
  • Tacrolimus